Home/Filings/4/0001493152-24-047695
4//SEC Filing

Murali Ramachandran 4

Accession 0001493152-24-047695

CIK 0001962011other

Filed

Nov 24, 7:00 PM ET

Accepted

Nov 25, 8:30 PM ET

Size

4.5 KB

Accession

0001493152-24-047695

Insider Transaction Report

Form 4
Period: 2024-11-25
Murali Ramachandran
VP of Research and Development
Transactions
  • Purchase

    COMMON STOCK

    2024-11-25$1.59/sh+200$318133,057 total

Documents

1 file

Issuer

Kairos Pharma, LTD.

CIK 0001962011

Entity typeother

Related Parties

1
  • filerCIK 0001870016

Filing Metadata

Form type
4
Filed
Nov 24, 7:00 PM ET
Accepted
Nov 25, 8:30 PM ET
Size
4.5 KB